Found 797 results
Filters: Keyword is Male  [Clear All Filters]
2023
Kim SH, Chang SJung Chris, Dobri G, Strauss S, Lin E, Zavaletta V, Pannullo SC, Osborne JR, Schwartz TH, Knisely JPS et al..  2023.  [68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort.. Pituitary. 26(4):419-428.
Li G, Tong R, Zhang M, Gillen KM, Jiang W, Du Y, Wang Y, Li J.  2023.  Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.. Neuroimage. 269:119923.
Subramanian K, Martinez J, Castellanos SHuicochea, Ivanidze J, Nagar H, Nicholson S, Youn T, Nauseef JT, Tagawa S, Osborne JR.  2023.  Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men.. Sci Rep. 13(1):8321.
Yun H, Kim J, Gandhe A, Nelson B, Hu JC, Gulani V, Margolis D, Schackman BR, Jalali A.  2023.  Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results.. JAMA Netw Open. 6(11):e2344856.
Jett S, Dyke JP, Yepez CBoneu, Zarate C, Carlton C, Schelbaum E, Jang G, Pahlajani S, Williams S, Brinton RDiaz et al..  2023.  Effects of sex and APOE ε4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy study.. PLoS One. 18(2):e0281302.
Kim J, Kaylor K, Lamparello N.  2023.  The Gender Gap in Interventional Radiology: Barriers, Opportunities, and the Role of the Integrated IR Residency.. Acad Radiol. 30(11):2749-2756.
Bukhari H, Su C, Dhamala E, Gu Z, Jamison K, Kuceyeski A.  2023.  Graph-matching distance between individuals' functional connectomes varies with relatedness, age, and cognitive score.. Hum Brain Mapp. 44(9):3541-3554.
Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L et al..  2023.  Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).. Eur J Nucl Med Mol Imaging. 50(9):2830-2845.
Kang Z, Margolis DJ, Wang S, Li Q, Song J, Wang L.  2023.  Management Strategy for Prostate Imaging Reporting and Data System Category 3 Lesions.. Curr Urol Rep. 24(12):561-570.
Machado CML, Skubal M, Haedicke K, Silva FP, Stater EP, Silva TLA de O, Costa ET, Masotti C, Otake AH, Andrade LNS et al..  2023.  Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumors.. J Control Release. 364:312-325.
Jarrett DY, Stamoulis C, Shore BJ, Tsai A.  2023.  Pelvis radiographs in children with cerebral palsy: effects of patient positioning on calculating migration percentages.. Pediatr Radiol. 53(13):2662-2671.
Stangl-Kremser J, Sun M, Ho B, Thomas J, Nauseef JT, Osborne JR, Molina A, Sternberg CN, Nanus DM, Bander NH et al..  2023.  Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.. Prostate. 83(14):1351-1357.
Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, Cho SY, Fanti S, Giesel FL, Goffin K et al..  2023.  PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.. Eur J Nucl Med Mol Imaging. 50(5):1466-1486.
Dimov AV, Li J, Nguyen TD, Roberts AG, Spincemaille P, Straub S, Zun Z, Prince MR, Wang Y.  2023.  QSM Throughout the Body.. J Magn Reson Imaging. 57(6):1621-1640.
Boneva SK, Nguyen JH, Gui W, Hoerig C, Mamou J, Ketterling JA, Chong LP, Sebag J.  2023.  RECURRENT FLOATERS AFTER LIMITED VITRECTOMY FOR VISION DEGRADING MYODESOPSIA.. Retina. 43(7):1114-1121.
Zhao W, Yang C, Tong R, Chen L, Chen M, Gillen KM, Li G, Ma C, Wang Y, Wu X et al..  2023.  Relationship Between Iron Distribution in Deep Gray Matter Nuclei Measured by Quantitative Susceptibility Mapping and Motor Outcome After Deep Brain Stimulation in Patients With Parkinson's Disease.. J Magn Reson Imaging. 58(2):581-590.
Stangl-Kremser J, Ricaurte-Fajardo A, Subramanian K, Osborne JR, Sun M, Tagawa ST, Bander NH.  2023.  Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literature.. Prostate. 83(10):901-911.
Kim H, Kang SWon, Kim J-H, Nagar H, Sabuncu M, Margolis DJA, Kim CKyo.  2023.  The role of AI in prostate MRI quality and interpretation: Opportunities and challenges.. Eur J Radiol. 165:110887.
Hope TA, Antonarakis ES, Bodei L, Calais J, Iravani A, Jacene H, Koo PJ, Morgans AK, Osborne JR, Tagawa ST et al..  2023.  SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy.. J Nucl Med. 64(9):1417-1423.
Luo Y, Yamada M, N'Tumba-Byn T, Asif H, Gao M, Hu Y, Marangoni P, Liu Y, Evans T, Rafii S et al..  2023.  SPRY4-dependent ERK negative feedback demarcates functional adult stem cells in the male mouse germline†.. Biol Reprod. 109(4):533-551.
Rogers HJ, Singh S, Barnes A, Obuchowski NA, Margolis DJ, Malyarenko DI, Chenevert TL, Shukla-Dave A, Boss MA, Punwani S.  2023.  Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition.. Eur J Radiol. 162:110782.
Iwasaka-Neder J, Bixby SD, M Bedoya A, Liu E, Jarrett DY, Agahigian D, Tsai A.  2023.  Virtual 3D femur model to assess femoral version: comparison to the 2D axial slice approach.. Pediatr Radiol. 53(12):2411-2423.